THE SHARE: Change: -0.01 SEK (-2.78%) / Price: 0.35 SEK / Sep 25, 2023, 1:23 pm (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

Prospectus

  • 9 Jun, 2022
    Spago Nanomedical offentliggör prospekt avseende företrädesemission samt uppdaterar om säkerställandegrad
  • 9 Jun, 2022
    Spago Nanomedical publishes prospectus relating to the rights issue and gives update regarding the level of undertaking
  • 8 Feb, 2021
    Spago Nanomedical AB (publ) offentliggör prospekt avseende företrädesemission om cirka 59,1 MSEK
  • 24 Apr, 2020
    Spago Nanomedical AB (publ) offentliggör prospekt
  • 26 Sep, 2017
    Spago Nanomedical offentliggör prospekt
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2023 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications